One promising angiogenic therapy for inner ear disorders is the delivery of vascular endothelial growth factor (VEGF), a potent pro-angiogenic factor that can stimulate endothelial cell proliferation, migration, and tube formation [211]. This evidence concerns the gene VEGFA and inner ear disorder.